Insider Selling: Oscar Health (NYSE:OSCR) Insider Sells 9,859 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) insider Adam Mcananey sold 9,859 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $216,306.46. Following the sale, the insider directly owned 218,096 shares of the company’s stock, valued at $4,785,026.24. This represents a 4.32% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Oscar Health Price Performance

OSCR traded up $3.04 on Thursday, hitting $23.54. 10,532,228 shares of the stock were exchanged, compared to its average volume of 7,845,401. Oscar Health, Inc. has a 12 month low of $10.69 and a 12 month high of $25.58. The business has a 50-day moving average of $17.92 and a two-hundred day moving average of $15.93. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.11 and a quick ratio of 1.11. The firm has a market capitalization of $7.10 billion, a price-to-earnings ratio of -39.90, a PEG ratio of 1.48 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last issued its earnings results on Wednesday, May 6th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $1.11 by $0.96. The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The business’s quarterly revenue was up 52.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.92 earnings per share. Sell-side analysts forecast that Oscar Health, Inc. will post 0.47 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Quarry LP boosted its stake in Oscar Health by 439.8% in the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock worth $34,000 after purchasing an additional 1,469 shares during the period. Tsfg LLC bought a new position in Oscar Health in the 3rd quarter worth about $38,000. Jones Financial Companies Lllp boosted its stake in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after purchasing an additional 2,242 shares during the period. Strs Ohio bought a new position in Oscar Health in the 1st quarter worth about $30,000. Finally, Fifth Third Bancorp boosted its stake in Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company’s stock worth $34,000 after purchasing an additional 1,413 shares during the period. Institutional investors own 75.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on OSCR. Wells Fargo & Company set a $20.00 price target on Oscar Health and gave the stock an “equal weight” rating in a report on Thursday. Raymond James Financial raised Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research report on Thursday, February 12th. Barclays lifted their price objective on Oscar Health from $21.00 to $30.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 26th. UBS Group lifted their price objective on Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Finally, Robert W. Baird lifted their price objective on Oscar Health from $15.00 to $19.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $20.22.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.